Predictors of high-cost hospitalization in the treatment of acute coronary syndrome in Asia: findings from EPICOR Asia

• DOI: 10.1186/s12872-018-0859-4
• Publication Date: 2018-07-04T09:18:28Z
• Authors: Stephen Jan; Stephen W-L. Lee; Jitendra P. S. Sa...; Tiong K. Ong; Chee Tang Chin; Hyo-Soo Kim; Rungroj Krittayap...; Vo T. Nhan; Stuart J. Pocock; Ana M. Vega; Nobuya Hayashi; Yong Huo
• Keywords: Angiology

The EPICOR Asia (long-tErm follow-uP of antithrombotic management patterns In acute CORonary syndrome patients in Asia) study (NCT01361386) was an observational hospitalized for coronary syndromes (ACS) enrolled 218 hospitals eight countries/regions Asia. This examined costs, length stay and the predictors high costs during ACS hospitalization. Data (n = 12,922) were collected on demographics, medical history, event characteristics, socioeconomic insurance status at discharge. Patients followed up 6 weeks' post-hospitalization to assess associated treatment from a health sector perspective. Primary outcome incurring highest quintile by country index diagnosis, identification predictors. Cost data available 10,819 patients. Mean 10.1 days. highest-cost countries China, Singapore, South Korea. Significant high-cost care age, male sex, income, country, prior disease hospitalization 3 months before event, no dependency having invasive procedure, hospital type stay. Substantial variability exists healthcare across Of concern is observation that reported given rapidly increasing numbers procedures recent years. NCT01361386 .